RISE CAB training package
>
Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 11 - 20 of 78

Selected Filters:
28 October 2022

HIV & AIDS Information for Health Professionals

Developed by the New Zealand Ministry of Health, this page has links to a range of research and related information on HIV and AIDS.

Normative Guidance/Policies

External Link
27 October 2022

England HIV/AIDS Action Plan, 2022-25

A plan aimed at building on recent successes, the goal put forth in this document is zero new infections by 2030.

Monitoring & Evaluation

External Link
13 October 2022

Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study

This article from the Journal of the International AIDS Society assesses factors associated with long-term PrEP engagement and adherence among trans women enrolled in the Implementation of PrEP (ImPrEP) study, the largest PrEP demonstration study in Latin America.

Research

External Link
1 September 2022

Including Pregnant and Lactating Populations in HIV Prevention Research

For prevention options to meet the real life circumstances of the people who need them, we need an inclusive research agenda. Advocacy for the inclusion of pregnant and lactating populations (PLP) in research has been gaining traction in recent years. This page has a library of resources that provide background on the issue, update on…

Community/Advocacy, Research

External Link
15 August 2022

By women, for women: A story of rings, research and resolve

This dynamic photo story from the International Partnership for Microbicides explains how the dapivirine vaginal ring was conceived, and the journey it has taken to becoming an HIV prevention choice for women.

Community/Advocacy, Research

External Link
12 August 2022

HIV Prevention Research and Development Database

The HIV Prevention Research & Development Database is a comprehensive source of information on biomedical HIV prevention clinical trials that are planned, ongoing or completed. The database allows users to view clinical trials around the world, gaining an understanding of the many developments currently being made in the field of HIV prevention research.

Research

External Link
12 August 2022

A Plan for Accelerating Access and Introduction of Injectable CAB for PrEP

AVAC’s Plan for Accelerating Access and Introduction of Injectable Cabotegravir (CAB) for PrEP provides a comprehensive view of all the moving parts involved in delivering this new PrEP option and identifies priorities for ensuring time is not wasted and opportunity is not squandered. The plan focuses on learning the lessons from the first ten years…

Community/Advocacy

External Link
9 August 2022

AIDSVu

AIDSVu is an interactive online mapping tool that visualizes the impact of the HIV epidemic on communities across the United States to increase disease awareness and promote data-driven public health decision-making. This includes information on PrEP use and need from national to city level.

Monitoring & Evaluation

External Link
8 August 2022

Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women

This press release provides an overview of the new findings from HPTN 084, a trial of the HIV Prevention Trials Network studying injectable cabotegravir for PrEP among cisgender women. The updated results show reductions in HIV incidence were sustained in the 12 months following unblinding and were presented at the AIDS 2022 conference in Montreal.

Research

External Link
4 August 2022

AVAC, BMGF, CIFF, MedAccess, Unitaid and ViiV Healthcare announce collaboration to catalyse more affordable access to long- acting injectable cabotegravir for HIV prevention

AVAC press release announcing a new collaboration focused on pricing, innovative funding mechanisms, tracking regulatory approvals, and ensuring the inclusion of civil society in key planning and decision making to speed access to injectable cabotegravir (CAB) for PrEP. Launched at the 24th International AIDS Conference, this collaboration includes AVAC, the Bill and Melinda Gates Foundation,…

Community/Advocacy

External Link